September 14, 2021

Hearing is Believing: FRONICS Creates World’s First Sensor to Enable Machines to Hear Like Humans

FRONICS super hearing machine, overcomes microphone limitations to recognize human sound! FRONICS team in San Francisco Sept. 9, 2021 SAN FRANCISCO, Sept. 14, 2021 (GLOBE NEWSWIRE) — Fronics Inc., a technology company from South Korea, opens a new horizon for machine learning with the advancement of an artificial ear. Most people know that various kinds of microphones […]

Read More

The Hyris System™ Detects SARS-CoV-2, Including Recently Emerged Variants of Concerns.

As new mutations of SARS-CoV-2 keep spreading worldwide, Hyris keeps monitoring its test kits effectiveness, performing routine analysis of SARS-CoV-2 variants to safeguard public health and the product’s quality by assessing the potential impact of new strains on sensitivity and specificity. Hyris System™ for Covid-19 diagnostics LONDON, England, Sept. 14, 2021 (GLOBE NEWSWIRE) — New […]

Read More

Anaqua Delivers Enhanced IP Management to Bausch Health

Anaqua’s AQX platform to provide patent and trademark management with integrated IP analytics BOSTON, Sept. 14, 2021 (GLOBE NEWSWIRE) — Anaqua, the leading innovation and intellectual property management technology provider, today announced that Bausch Health Companies Inc. has selected Anaqua’s AQX platform to deliver enhanced IP management across the health care products company’s global operations. […]

Read More

Teledyne e2v introduces the industry’s smallest 2MP & 1.5MP CMOS sensors, featuring a low-noise global shutter pixel

New Topaz sensors are ideal for mobile applications, offering an attractive price point with no-compromise performance. Teledyne e2v’s new Topaz sensor for high-volume applications GRENOBLE, France, Sept. 14, 2021 (GLOBE NEWSWIRE) — Teledyne e2v, a part of Teledyne Technologies [NYSE: TDY], has introduced its Topaz series of industrial CMOS sensors with new 2MP and 1.5MP […]

Read More

Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric Collapse

INSIDE INFORMATION REGULATED INFORMATION Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric Collapse Mont-Saint-Guibert (Belgium), September 14, 2021, 8:00 am CET / 2:00 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and […]

Read More

Francesco Tanzi named Chief Financial Officer of new Iveco Group

CNH INDUSTRIAL N.V. London, September 14, 2021 CNH Industrial (NYSE: CNHI / MI: CNHI) announces an important appointment to the future Senior Leadership Team of Iveco Group, the Company previously referred to as the “On-Highway” business of CNH Industrial, which will begin independent operations in early 2022. Effective January 1, 2022, Francesco Tanzi will join […]

Read More

KnowledgeIQ, a Solution by Knosys, Announces Its Integration With Salesforce for Improved Customer and Agent Experience

PORT MELBOURNE, Australia, Sept. 14, 2021 (GLOBE NEWSWIRE) — Knosys today announced that its knowledge management solution, KnowledgeIQ (www.knoiq.co) has launched a new integration with Salesforce. With KnowledgeIQ and Salesforce, your customer-facing teams can effortlessly access the right information and answers sourced from their entire business to make sales, drive exceptional customer experiences and improve […]

Read More

Positive Interim Results of CHOICE-01 Study Evaluating Junshi Biosciences and Coherus’ Toripalimab for First Line Treatment of Non-Small Cell Lung Cancer Presented at World Conference on Lung Cancer

SHANGHAI, China and REDWOOD CITY, Calif., Sept. 14, 2021 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus Biosciences, Inc. (Nasdaq: CHRS) announced the presentation today of positive interim results from the pivotal study “CHOICE-01” (NCT03856411), a randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating toripalimab plus chemotherapy […]

Read More

Recent Posts